An Algorithm for the Management of Explantation Surgery

Calobrace, M. Bradley; Mays, Chet

doi:10.1016/j.cps.2020.09.005

Cited by 10 publications

(15 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this situation, capsulectomy is warranted if the capsule is thick or calcified, has a mass present, or is embedded with silicone. 39 Calcified or thick capsules should be excised to minimize breast distortion and interference with future screening mammograms. 40 A soft capsule can be left intact as capsulectomy is not without risks such as hematoma, pneumothorax, and possible undesirable aesthetic outcome.…”

Section: Treatmentmentioning

confidence: 99%

“…40 A soft capsule can be left intact as capsulectomy is not without risks such as hematoma, pneumothorax, and possible undesirable aesthetic outcome. 39 If implant retention is desired, then strong consideration should be made for placing a new implant in a new site or pocket. 2 The gold standard of treatment is capsulectomy, implant exchange, and possible site change.…”

Section: Treatmentmentioning

confidence: 99%

“…40 Given the risk of pneumothorax with posterior capsulectomy, the posterior capsule can instead be obliterated with cauterization. 39 ►Fig. 1 shows a patient with a smooth silicone implants in the subpectoral plane with bilateral grade III capsular contracture.…”

Section: Treatmentmentioning

confidence: 99%

“…[78][79][80] The technique involves a superiorly based mastopexy with a deepithelialized inferior dermoglandular flap that is flipped under the areola and breast and sutured to the overlying breast tissue. 39 Fat grafting can be applied with or without implant replacement and with or without mastopexy. Fat grafting can improve global volume, including upper pole and cleavage volume, but is poor at creating core projection.…”

Section: Breast Ptosis and Aging Breasts Following Breast Augmentationmentioning

confidence: 99%

See 3 more Smart Citations

Revision Breast Augmentation

et al. 2021

View full text Add to dashboard Cite

Breast augmentation is consistently one of the most commonly performed aesthetic operations every year. Unfortunately, revision rates following primary augmentation remain as high as 36%. There are several causes for revision breast augmentation; however, the most common and challenging of these include capsular contracture, implant malposition, and ptosis of the aging breast following augmentation. Successful management of these problems requires knowledge on how to best treat the implant and capsule with the corresponding soft tissue simultaneously. While surgical management is important, understanding the pathological causes of these entities during the primary operation can reduce the need for revision. This article utilizes the most up-to-date literature to review the appropriate clinical evaluation and surgical management of these complex cases.

show abstract

Section: Treatmentmentioning

confidence: 99%

Section: Treatmentmentioning

confidence: 99%

Section: Treatmentmentioning

confidence: 99%

Section: Breast Ptosis and Aging Breasts Following Breast Augmentationmentioning

confidence: 99%

See 2 more Smart Citations

Revision Breast Augmentation

et al. 2021

View full text Add to dashboard Cite

show abstract

“…20 There is insufficient evidence linking prophylactic implant exchange and/or capsulectomy with BIA-ALCL risk reduction, and these surgeries still carry the risk of complications. 21,22 Still, the risk of developing BIA-ALCL can cause significant psychological distress for some patients, so referral to a plastic surgeon for a discussion regarding implant removal may be beneficial for these patients. 19,23…”

Section: General Breast Implant Carementioning

confidence: 99%

Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines

et al. 2021

View full text Add to dashboard Cite

Breast implant surgery for cosmetic or reconstructive purposes is becoming increasingly common. While the devices used are regulated and approved by the US Food and Drug Administration, all patients with breast implants require continued follow-up. Many patients will seek this care from their primary care providers, especially when follow-up with their plastic surgeon is difficult. It is vital that treating clinicians are knowledgeable about the history of breast implants, routine screening guidelines, and the recent breast implant "hot topics"-breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), connective tissue disease, and breast implant illness. This paper will provide the necessary information for primary care providers to appropriately counsel patients with breast implants to maintain not only their trust, but also their health. Abbreviations BIA-ALCLBreast implant-associated anaplastic large cell lymphoma FDA US Food and Drug Administration MRI Magnetic resonance imaging TNM Tumor, node, metastasis

show abstract

Breast Implant Illness (BII): Real Syndrome or a Social Media Phenomenon? A Narrative Review of the Literature

Atiyeh

Emsieh

2021

Aesth Plast Surg

View full text Add to dashboard Cite

An Algorithm for the Management of Explantation Surgery

Cited by 10 publications

References 38 publications

Revision Breast Augmentation

Revision Breast Augmentation

Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines

Breast Implant Illness (BII): Real Syndrome or a Social Media Phenomenon? A Narrative Review of the Literature

Contact Info

Product

Resources

About